CroiValve
Latest round
- Series B
Last raised
- Jun 2026
Total raised
- $34M
Investors
- 13
About CroiValve
CroiValve is a medical technology company focused on developing advanced solutions for the treatment of severe Tricuspid Regurgitation, providing innovative options for improving patient outcomes in cardiovascular care. Based in Dublin, Ireland and founded in 2016, CroíValve Limited provides transcatheter cardiovascular devices for the structural heart disease market. The company develops innovative solutions for treating tricuspid regurgitation, a condition associated with significant morbidity and limited treatment options. CroíValve was founded by Fionn Lahart, who continues to lead the company as a CEO. The company works with physicians, hospitals, and cardiovascular specialists to provide transcatheter therapies for patients with tricuspid regurgitation. CroíValve’s flagship product is the DUO™ Adapt System, an investigational transcatheter heart valve designed to preserve native valve anatomy while reducing regurgitation. The technology utilizes an adaptive coaptation approach that accommodates varying leak geometries and complex patient anatomies. The company’s engineers, clinical specialists, regulatory professionals, and research teams support device development, clinical validation, and regulatory activities. Its solutions target structural heart disease treatment within the global interventional cardiology and medical technology markets. The company’s revenue is generated by future commercialization opportunities associated with its structural heart disease technologies and related medical device products. CroíValve develops proprietary transcatheter valve technologies intended for use by hospitals, cardiac centers, and healthcare providers. Its business model is centered on advancing clinical evidence, securing regulatory approvals, and establishing partnerships with healthcare systems and medical technology stakeholders.S. and European sites.
Who invested in CroiValve
13 investors across 4 rounds
See all investors in CroiValve
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CroiValve
Who invested in CroiValve?
CroiValve has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CroiValve raised?
CroiValve has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did CroiValve last raise money?
CroiValve's most recent round on record is a Series B, in Jun 2026.
What does CroiValve do?
CroiValve is a medical technology company focused on developing advanced solutions for the treatment of severe Tricuspid Regurgitation, providing innovative options for improving patient outcomes in cardiovascular care.
Where is CroiValve headquartered?
CroiValve is headquartered in Dublin, Ireland.
Which VCs invest in companies like CroiValve?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at CroiValve's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like CroiValve? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.